ENZYMOTEC LTD's ticker is ENZY and the CUSIP is M4059L101. A total of 20 filers reported holding ENZYMOTEC LTD in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $130,000 | +4.0% | 10,987 | 0.0% | 0.00% | – |
| Q3 2017 | $125,000 | +42.0% | 10,987 | 0.0% | 0.00% | – |
| Q2 2017 | $88,000 | -30.2% | 10,987 | -23.6% | 0.00% | – |
| Q1 2017 | $126,000 | +88.1% | 14,383 | +38.9% | 0.00% | – |
| Q4 2016 | $67,000 | -5.6% | 10,355 | +1.7% | 0.00% | – |
| Q3 2016 | $71,000 | -15.5% | 10,183 | +0.4% | 0.00% | – |
| Q2 2016 | $84,000 | -26.3% | 10,140 | -19.8% | 0.00% | – |
| Q1 2016 | $114,000 | – | 12,640 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIGER MANAGEMENT L.L.C. | 1,143,145 | $10,323,000 | 2.59% |
| Visium Asset Management, LP | 2,200,000 | $19,866,000 | 0.34% |
| Paulson & Co. | 4,224,139 | $38,144,000 | 0.28% |
| ALGERT GLOBAL LLC | 20,988 | $190,000 | 0.07% |
| MENTA CAPITAL LLC | 43,126 | $389,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 61,844 | $558,000 | 0.04% |
| Acrospire Investment Management LLC | 2,785 | $25,000 | 0.02% |
| ICON ADVISERS INC/CO | 16,800 | $152,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 168,738 | $1,523,000 | 0.01% |
| Renaissance Technologies | 181,000 | $1,634,000 | 0.00% |